Physician profile
Mitchell A Bitran
NPI 1356845903
$1,119.79
in general payments reported to CMS, 2019-2025
14 companies · $563 in 2025
The $563 reported for 2025 was more than what 83% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $105 · 2023: $322 · 2024: $130 · 2025: $563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $930 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $929.95 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $240.94 | 2025 | |
| Astellas Pharma US INC | $240.17 | 2023-2025 | Veozah |
| Hologic Sales and Service, LLC | $117.77 | 2023-2025 | Aptima, Thinprep 2000 Processor |
| Biogen, INC. | $104.21 | 2024-2025 | Zurzuvae |
| Abbvie INC. | $100.04 | 2022-2023 | Lo Loestrin Fe |
| Exeltis, USA INC. | $75.87 | 2022-2023 | Slynd |
| Axonics, INC. | $57.94 | 2023 | Axonics |
| Organon LLC | $43.67 | 2022-2023 | |
| Evofem Biosciences, INC. | $39.85 | 2024-2025 | Solosec, Phexx, Phexxi |
| Baxter Healthcare | $30.22 | 2025 | Perclot |
| Therapeuticsmd, INC. | $20.78 | 2022 | |
| Sumitomo Pharma America, INC. | $20.01 | 2025 | Gemtesa |
| Optumhealth Care Solutions, LLC | $14.34 | 2024 | Vivify Health Care Team Portal 001, Eitan Medical |
| Coopersurgical, INC. | $13.98 | 2025 | Paragard T 380a |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Bitran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.